{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:09:19Z","timestamp":1784070559404,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012464","name":"Kaleida Health Foundation","doi-asserted-by":"publisher","award":["Troup Fund"],"award-info":[{"award-number":["Troup Fund"]}],"id":[{"id":"10.13039\/100012464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011668","name":"Empire State Development","doi-asserted-by":"publisher","award":["Buffalo Innovation Accelerator Fund"],"award-info":[{"award-number":["Buffalo Innovation Accelerator Fund"]}],"id":[{"id":"10.13039\/100011668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13539-5","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:07:16Z","timestamp":1779350836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C care cascade using direct-acting antivirals in rural new York State from 2013 to 2023: a retrospective observational study"],"prefix":"10.1186","volume":"26","author":[{"given":"Zoi","family":"Papalamprakopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa B.","family":"Scribani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Krupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Victory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Dharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy M.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Freilich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Talal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"13539_CR1","unstructured":"Centers for disease control and prevention (CDC). Viral hepatitis surveillance report \u2013 United States. 2022. https:\/\/www.cdc.gov\/hepatitis-surveillance-2022\/hepatitis-c\/index.html. Accessed 18 April 2025."},{"key":"13539_CR2","unstructured":"Viral hepatitis national strategic plan for the United States. a roadmap to elimination (2021\u20132025), 2020. https:\/\/www.hhs.gov\/sites\/default\/files\/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf. Accessed 12 Jan 2021."},{"key":"13539_CR3","unstructured":"World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030, 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240053779. Accessed: 21 Feb 2026."},{"issue":"5","key":"13539_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/jvh.13060","volume":"26","author":"HS Kim","year":"2019","unstructured":"Kim HS, Yang JD, El-Serag HB, Kanwal F. Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey. J Viral Hepat. 2019;26(5):596\u2013602.","journal-title":"J Viral Hepat"},{"issue":"26","key":"13539_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.15585\/mmwr.mm7226a3","volume":"72","author":"C Wester","year":"2023","unstructured":"Wester C, Osinubi A, Kaufman HW, Symum H, Meyer WA 3rd, Huang X, et al. Hepatitis C Virus Clearance Cascade - United States, 2013\u20132022. MMWR Morb Mortal Wkly Rep. 2023;72(26):716\u201320.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"13539_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12954-024-01131-6","volume":"21","author":"AT Estadt","year":"2024","unstructured":"Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, et al. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024;21(1):214.","journal-title":"Harm Reduct J"},{"issue":"2","key":"13539_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.14309\/ajg.0000000000003487","volume":"121","author":"AM Moon","year":"2026","unstructured":"Moon AM, Lupu GV, Green EW, Deutsch-Link S, Henderson LM, Sanoff HK, et al. Rural-Urban Disparities in Hepatocellular Carcinoma Deaths Are Driven by Hepatitis C-Related Hepatocellular Carcinoma. Am J Gastroenterol. 2026;121(2):353\u201361.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"13539_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/M17-1073","volume":"167","author":"PS Belperio","year":"2017","unstructured":"Belperio PS, Chartier M, Ross DB, Alaigh P, Shulkin D. Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs. Ann Intern Med. 2017;167(7):499\u2013504.","journal-title":"Ann Intern Med"},{"key":"13539_CR9","unstructured":"Centers for Disease Control and Prevention (CDC). Universal Hepatitis C Screening Among Adults and Treatment for Hepatitis C Virus Infection. 2024. https:\/\/www.cdc.gov\/high-impact-prevention\/php\/case-studies\/hepatitis-c-screening-treatment.html. Accessed 18 April 2025."},{"issue":"10","key":"13539_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jama.2020.1123","volume":"323","author":"US Preventive Services Task","year":"2020","unstructured":"US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, et al. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323(10):970\u20135.","journal-title":"JAMA"},{"issue":"12","key":"13539_CR11","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1111\/ajt.14555","volume":"17","author":"KA Mack","year":"2017","unstructured":"Mack KA, Jones CM, Ballesteros MF. Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas-United States. Am J Transpl. 2017;17(12):3241\u201352.","journal-title":"Am J Transpl"},{"key":"13539_CR12","doi-asserted-by":"crossref","unstructured":"Romo E, Bianchet E, Dowd P, Mazor KM, Stopka TJ, Friedmann PD. Syringe access, syringe sharing, and perceptions of: a qualitative study exploring the HCV risk environment in rural northern New England, United States. Viruses. 2024;16(9).","DOI":"10.3390\/v16091364"},{"key":"13539_CR13","doi-asserted-by":"publisher","first-page":"112498","DOI":"10.1016\/j.drugalcdep.2024.112498","volume":"266","author":"AM Ballard","year":"2025","unstructured":"Ballard AM, Kesich Z, Crane HM, Feinberg J, Friedmann PD, Go VF, et al. Rural houselessness among people who use drugs in the United States: Results from the National Rural Opioid Initiative. Drug Alcohol Depend. 2025;266:112498.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"13539_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11904-018-0393-0","volume":"15","author":"AJ Schranz","year":"2018","unstructured":"Schranz AJ, Barrett J, Hurt CB, Malvestutto C, Miller WC. Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C. Curr HIV\/AIDS Rep. 2018;15(3):245\u201354.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"7","key":"13539_CR15","doi-asserted-by":"publisher","first-page":"e2422406","DOI":"10.1001\/jamanetworkopen.2024.22406","volume":"7","author":"NW Furukawa","year":"2024","unstructured":"Furukawa NW, Ingber SZ, Symum H, Rapposelli KK, Teshale EH, Thompson WW, et al. Medicaid Expansion and Restriction Policies for Hepatitis C Treatment. JAMA Netw Open. 2024;7(7):e2422406.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"13539_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12954-025-01166-3","volume":"22","author":"Z Papalamprakopoulou","year":"2025","unstructured":"Papalamprakopoulou Z, Ntagianta E, Triantafyllou V, Kalamitsis G, Dharia A, Dickerson SS, et al. Breaking the vicious cycle of delayed healthcare seeking for people who use drugs. Harm Reduct J. 2025;22(1):27.","journal-title":"Harm Reduct J"},{"key":"13539_CR17","doi-asserted-by":"publisher","first-page":"103238","DOI":"10.1016\/j.drugpo.2021.103238","volume":"96","author":"T Goodyear","year":"2021","unstructured":"Goodyear T, Brown H, Browne AJ, Hoong P, Ti L, Knight R. \u201cStigma is where the harm comes from\u201d: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs. Int J Drug Policy. 2021;96:103238.","journal-title":"Int J Drug Policy"},{"key":"13539_CR18","unstructured":"Morse S. 7 insurers agree to expand coverage of chronic hepatitis C treatment, New York AG says. Healthcare Finance News, 2016. https:\/\/www.healthcarefinancenews.com\/news\/7-insurers-agree-expand-coverage-chronic-hepatitis-c-treatment-new-york-ag-says. Accessed April 27, 2026."},{"key":"13539_CR19","unstructured":"United States Census Bureau. Urban and rural classification and urban area criteria. 2010. https:\/\/www.census.gov\/programs-surveys\/geography\/guidance\/geo-areas\/urban-rural.html. Accessed 3 March\u00a0 2025."},{"key":"13539_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2307\/2532311","volume":"48","author":"JNK Rao","year":"1992","unstructured":"Rao JNK, Scott AL. A simple method for the analysis of clustered binary data. Biometrics. 1992;48:577\u201385.","journal-title":"Biometrics"},{"issue":"2","key":"13539_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/HEP.0000000000000927","volume":"81","author":"EW Hall","year":"2025","unstructured":"Hall EW, Bradley H, Barker LK, Lewis KC, Shealey J, Valverde E, et al. Estimating hepatitis C prevalence in the United States, 2017\u20132020. Hepatology. 2025;81(2):625\u201336.","journal-title":"Hepatology"},{"issue":"16","key":"13539_CR22","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jama.2024.2452","volume":"331","author":"AH Talal","year":"2024","unstructured":"Talal AH, Markatou M, Liu A, Perumalswami PV, Dinani AM, Tobin JN, et al. Integrated Hepatitis C\u2013Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial. JAMA. 2024;331(16):1369\u201378.","journal-title":"JAMA"},{"key":"13539_CR23","first-page":"100683","volume":"23","author":"AH Talal","year":"2026","unstructured":"Talal AH, Mukhopadhyay R, Veronesi V, Dharia A, Saraceno G, Fierer DS, et al. Improvements in substance use and social determinants of health associated with hepatitis C treatment initiation and sustained virologic response in opioid treatment programs. Addict Behav Rep. 2026;23:100683.","journal-title":"Addict Behav Rep"},{"issue":"2","key":"13539_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cgh.2019.04.035","volume":"18","author":"S Seo","year":"2020","unstructured":"Seo S, Silverberg MJ, Hurley LB, Ready J, Saxena V, Witt D, et al. Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017. Clin Gastroenterol Hepatol. 2020;18(2):511\u20133.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"13539_CR25","first-page":"117822182210958","volume":"16","author":"R Lasmanovich","year":"2022","unstructured":"Lasmanovich R, Shaked O, Sivan A, Barak I, Nahari M, Mor O, et al. Hepatitis C Virus Prevalence, Medical Status Awareness and Treatment Engagement among Homeless People Who use Drugs: Results of a Street Outreach Study. Subst Abuse. 2022;16:11782218221095871.","journal-title":"Subst Abuse"},{"issue":"6","key":"13539_CR26","doi-asserted-by":"publisher","first-page":"e0157062","DOI":"10.1371\/journal.pone.0157062","volume":"11","author":"P Roux","year":"2016","unstructured":"Roux P, Rojas Castro D, Ndiaye K, Debrus M, Protopopescu C, Le Gall JM, et al. Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study. PLoS ONE. 2016;11(6):e0157062.","journal-title":"PLoS ONE"},{"key":"13539_CR27","unstructured":"Delaware County Health Department. Community Health Assessment. Delaware County, NY, 2022\u20132024. https:\/\/www.bassett.org\/sites\/default\/files\/2023-03\/Delaware_County_Community_Health_Assessment_2022-2024.pdf. Accessed April 27, 2025."},{"key":"13539_CR28","unstructured":"Chenango County Health Department. Community Health Assessment. \/ Community Health Needs Assessment and Community Health Improvement Plan\/ Community Service Plan, 2022\u20132024. https:\/\/www.chenangocountyny.gov\/DocumentCenter\/View\/3059\/Chenango-County-Community-Health-Assessment-2022-to-2024-PDF. Accessed April 27, 2025."},{"issue":"2","key":"13539_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.amepre.2020.08.031","volume":"60","author":"P Du","year":"2021","unstructured":"Du P, Wang X, Kong L, Riley T 3rd, Jung J. Changing Urban-Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014\u20132017. Am J Prev Med. 2021;60(2):285\u201393.","journal-title":"Am J Prev Med"},{"issue":"11","key":"13539_CR30","doi-asserted-by":"publisher","first-page":"e30632","DOI":"10.2196\/30632","volume":"23","author":"C Tsou","year":"2021","unstructured":"Tsou C, Robinson S, Boyd J, Jamieson A, Blakeman R, Yeung J, et al. Effectiveness of Telehealth in Rural and Remote Emergency Departments: Systematic Review. J Med Internet Res. 2021;23(11):e30632.","journal-title":"J Med Internet Res"},{"issue":"3","key":"13539_CR31","doi-asserted-by":"publisher","first-page":"37445","DOI":"10.52965\/001c.37445","volume":"10","author":"S Kolluri","year":"2022","unstructured":"Kolluri S, Stead TS, Mangal RK, Coffee RL Jr., Littell J, Ganti L. Telehealth in Response to the Rural Health Disparity. Health Psychol Res. 2022;10(3):37445.","journal-title":"Health Psychol Res"},{"issue":"3","key":"13539_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/cid\/ciae520","volume":"80","author":"A Seaman","year":"2025","unstructured":"Seaman A, Cook R, Leichtling G, Herink MC, Gailey T, Cooper J, et al. Peer-Assisted Telemedicine for Hepatitis C in People Who Use Drugs: A Randomized Controlled Trial. Clin Iinfect Dis. 2025;80(3):501\u20138.","journal-title":"Clin Iinfect Dis"},{"issue":"1","key":"13539_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13722-025-00541-6","volume":"20","author":"K Hoffman","year":"2025","unstructured":"Hoffman K, Leichtling G, Shin S, Seaman A, Gailey T, Spencer HC, et al. Peer-assisted telemedicine hepatitis-C treatment for people who use drugs in rural communities: a mixed methods study. Addict Sci Clin Pract. 2025;20(1):10.","journal-title":"Addict Sci Clin Pract"},{"issue":"2","key":"13539_CR34","first-page":"77","volume":"63","author":"TJ Stopka","year":"2025","unstructured":"Stopka TJ, Whitney BM, de Gijsel D, Brook DL, Friedmann PD, Taylor LE, et al. Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use Drugs. Med Care. 2025;63(2):77\u201388.","journal-title":"Med Care"},{"key":"13539_CR35","unstructured":"Herkimer County Health Department. Community Health Needs Assessment 2022\u20132024. https:\/\/www.herkimercountyny.gov\/download\/document.php?docid=1895. Accessed April 27, 2025."},{"key":"13539_CR36","unstructured":"Otsego County Health Department. Community Health Needs Assessment 2022\u20132024. https:\/\/www.bassett.org\/sites\/default\/files\/2023-03\/Otsego_County_Community_Health_Needs_Assessment_and_Community_Service_Plan_2022-2024.pdf. Accessed April 27, 2025."},{"key":"13539_CR37","unstructured":"Schoharie County Health Department. Community Health Needs Assessment 2022\u20132024. https:\/\/www.bassett.org\/sites\/default\/files\/2023-03\/Schoharie_County_Community_Health_Needs_Assessment_and_Community_Service_Plan_2022-2024.pdf. Accessed April 27, 2025."},{"key":"13539_CR38","doi-asserted-by":"publisher","first-page":"g1072","DOI":"10.1136\/bmj.g1072","volume":"348","author":"P Sedgwick","year":"2014","unstructured":"Sedgwick P. Retrospective cohort studies: advantages and disadvantages. BMJ. 2014;348:g1072.","journal-title":"BMJ"},{"issue":"8","key":"13539_CR39","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.4254\/wjh.v16.i8.1091","volume":"16","author":"M Alenzi","year":"2024","unstructured":"Alenzi M, Almeqdadi M. Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes. World J Hepatol. 2024;16(8):1091\u20138.","journal-title":"World J Hepatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13539-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13539-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13539-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:44:21Z","timestamp":1784069061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13539-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13539"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13539-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Mary Imogene Bassett Hospital Institutional Review Board, which issued a waiver of consent. The study complies with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AHT reported receiving nonfinancial support from Abbott Laboratories and Cepheid, Inc. and grants from Gilead Sciences, Novo Nordisk. AHT has served as a committee\/advisor for Gilead, AbbVie, Novo Nordisk, and Madrigal. He also serves as President of Empath Medical Innovations, None of the other authors report any competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1338"}}